Drugs / Pediarix/Infanrix Penta
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00345579 Background | Sep 2006 → Oct 2007 | haemophilus infectious disease, meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pediarix/Infanrix Penta | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00345579 ↗ |
| Modality | Vaccine | “Pediarix/Infanrix penta vaccine” NCT00345579 ↗ |
| Route | Intramuscular | “co-administered Pediarix/Infanrix penta vaccine was injected intramuscularly in the upper left thigh” NCT00345579 ↗ |